XTANT MED HLDGS INC's ticker is XTNT and the CUSIP is 98420P100. A total of 16 filers reported holding XTANT MED HLDGS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $1,000 | 0.0% | 1,167 | -31.0% | 0.00% | – |
| Q3 2017 | $1,000 | 0.0% | 1,692 | 0.0% | 0.00% | – |
| Q2 2017 | $1,000 | 0.0% | 1,692 | 0.0% | 0.00% | – |
| Q1 2017 | $1,000 | 0.0% | 1,692 | 0.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 1,692 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | -33.3% | 1,692 | 0.0% | 0.00% | – |
| Q2 2016 | $3,000 | -40.0% | 1,692 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | 0.0% | 1,692 | 0.0% | 0.00% | – |
| Q4 2015 | $5,000 | – | 1,692 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 422,800 | $1,184,000 | 1.27% |
| BARD ASSOCIATES INC | 136,751 | $383,000 | 0.23% |
| OUTFITTER ADVISORS, LTD. | 126,468 | $354,000 | 0.14% |
| Orbimed Advisors | 475,439 | $1,331,000 | 0.01% |
| Winslow, Evans & Crocker, Inc. | 15,112 | $42,314,000 | 0.01% |
| Texas Yale Capital Corp. | 10,000 | $28,000 | 0.00% |
| Cambridge Investment Research Advisors, Inc. | 16,400 | $46,000 | 0.00% |
| Walleye Trading LLC | 300 | $1,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 5 | $0 | 0.00% |
| MORGAN STANLEY | 2,660 | $8,000 | 0.00% |